-The Tribune Sangrur (Punjab): The number of Patients facing respiratory problems has gone up in the area these days. The trend is being attributed to burning of paddy stubble in the fields by farmers. Doctors say the number of Patients suffering from throat infections, allergic bronchitis, productive cough, asthma, itching and burning in eyes has doubled these days. Despite a ban on burning paddy stubble, around 75 per cent of the paddy...

-The Hindu Millets in one's diet can help prevent diabetes,says Dr. Vijay Viswanathan Diabetes mellitus is a metabolic disorder in which a person has high blood glucose (sugar), either because of inadequate insulin production, or because the body's cells do not respond properly to insulin, or both. Prolonged exposure to diabetes damages important organs like the eye, the kidney, the heart and nerves, as the result of damage to small blood vessels. Heredity,...

-The Times of India NEW DELHI: Air quality in the city is deteriorating every day as agricultural waste burning continues unabated in Punjab and Haryana. Doctors, too, are seeing a jump in cases of acute bronchitis, chronic obstructive pulmonary diseases (COPD) and asthma. They are advising those who are vulnerable or already suffering from respiratory disorders to avoid going out during peak traffic hours, keeping inhalers handy and, if smog is...

-Outlook New Delhi: The air quality in the national has deteriorated significantly and experts identified burning of agricultural wastes in neighbouring states as one of the major contributors to a visible haze over the city. As per official data, the air quality in the city has slipped into the category of "poor" following rapid increase of PM2.5 (respirable particles) level. The Air Quality Index value, calculated on the basis of PM 2.5 level,...

-Down to Earth Pharma company's strategy of different prices for different countries to affect quality treatment of 185 million people infected with Hepatitis C worldwide Health activists and agencies on Tuesday criticised leading pharmaceutical company Bristol-Myers Squibb (BMS)'s commercial strategy to sell new Hepatitis C medicine Daclatasvir, stating it would exclude a large number of Patients who cannot afford expensive treatment. BMS had announced that it would create a tiered pricing strategy for...